Article Abstract

Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer

Authors: Maciej Oszczudlowski, Jakub Dobruch

Abstract

Despite complete transurethral resection of bladder tumor (TURBT) and adjuvant intravesical treatment, relevant proportion of patients with non-muscle invasive bladder cancer (NMIBC) experience disease recurrence or progression (1).